Exciting expansion of Penn startup Passage Bio with Penn’s Gene Therapy Program led by Dr. Jim Wilson

Passage Bio emerged early last year with a sizable war chest, five gene therapy programs from the University of Pennsylvania and the option to license seven more. Now, the company is doubling down on that partnership, promising the university $5 million a year in exchange for access to more programs and new technologies that come out of the deal.

Read more on Fierce BioTech

Skip to content